. 2016 Nov 15;57(5):616–626. doi: 10.1002/jcph.840
© 2016, The Authors. The Journal of Clinical Pharmacology published by Wiley Periodicals, Inc. on behalf of American College of Clinical Pharmacology
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Figure 5.
Model‐predicted time course of LDL‐C after multiple SC evolocumab doses.